Bulk Pharmaceutical API Sources for OCUPRESS

Bulk Pharmaceutical API Sources for OCUPRESS

Vendor	Vendor Homepage	Vendor Sku	API Url
Finetech Industry Limited		FT-0640026
AbaChemScene		CS-2955
MedChemexpress MCE		HY-17495A
Molport		MolPort-006-129-555
AvaChem Scientific		1591

Bulk API Sources for OCUPRESS

Last updated: February 20, 2026

Ocupress, a synthetic prostaglandin analog used primarily for glaucoma treatment, contains the active pharmaceutical ingredient (API) known as Bimatoprost. Availability and sourcing of bulk Bimatoprost are critical for manufacturing, compliance, and supply chain management.

API Manufacturing and Supply Chain Overview

Bimatoprost is predominantly produced through chemical synthesis involving multiple steps to ensure high purity and stability. Major pharmaceutical ingredient suppliers span regions with established chemical manufacturing sectors, with a focus on low-cost manufacturing and strict quality controls.

Key API Producers

Company Name	Location	Capabilities	Certification	Supply Focus
Sandoz (Novartis)	Switzerland	Large-scale synthesis	GMP, ISO 9001	Global, dedicated to ophthalmic APIs
Cipla	India	Custom synthesis, bulk API	GMP, ISO certified	Oral and ophthalmic APIs, including Bimatoprost
PhibroChem	India, China	Specialty chemicals	GMP, cGMP	Focus on ophthalmic and cosmetic APIs
Acepharm	China	API manufacturing	GMP	Emerging supplier, with focus on ophthalmics
Ajanta Pharmaceuticals	India	API synthesis	GMP	Focus on ophthalmological APIs

Regional API Production Trends

• India: Dominates herbal and synthetic API manufacturing, supported by government policies incentivizing Quality by Design (QbD) and Good Manufacturing Practices (GMP). Several companies can produce Bimatoprost in compliance with international standards.

• China: Provides large volume, cost-effective API synthesis options. Many manufacturers operate under GMP and have export licenses for global markets.

• Europe: Focuses on high-quality, GMP-certified APIs for niche markets, less volume but stricter quality standards.

• United States: Contract manufacturers and specialty API producers with stringent regulatory oversight, mainly for domestic or high-standard export markets.

Quality Standards and Regulatory Compliance

API suppliers are required to meet specific quality standards:

• GMP Certification: Ensures manufacturing processes align with regulatory requirements.
• ISO Certifications: Demonstrates adherence to international quality management standards.
• Audit and Inspection Readiness: Suppliers regularly undergo audits by regulatory agencies such as the US FDA, EMA, and local authorities.

Market Dynamics and Sourcing Considerations

• Price Sensitivity: Indian and Chinese suppliers offer competitive prices with varying degrees of quality assurance.
• Supply Reliability: Large, established suppliers like Sandoz and Cipla maintain consistent supply chains and regulatory documentation.
• Intellectual Property: Bimatoprost manufacturing involves proprietary synthesis pathways. Sourcing from authorized, licensed manufacturers avoids legal and patent issues.
• Portfolio Diversification: Buyers often engage multiple suppliers to mitigate risks associated with supply disruptions or quality lapses.

Contracting and Procurement Strategies

• Long-term Agreements: Secure supply continuity and pricing stability.
• Sample Testing: Require comprehensive quality data and sample testing before large orders.
• Regulatory Documentation: Verify Certificates of Analysis (CoA), Batch Records, and compliance with regulatory submissions.

Summary

Major global suppliers for Bimatoprost as the API for Ocupress include:

• Sandoz (Switzerland)
• Cipla (India)
• PhibroChem (India/China)
• Acepharm (China)
• Ajanta Pharmaceuticals (India)

Sourcing from established suppliers with GMP certification and regulatory approval ensures API quality and supply security.

Key Takeaways

• Bimatoprost is produced mainly by Indian, Chinese, and European manufacturers.
• Large firms like Sandoz and Cipla provide reliable supply chains with strict quality controls.
• Price, quality, and regulatory compliance influence supplier choice.
• Diversification of suppliers mitigates risks.

FAQs

Q1: What are the primary regions for Bimatoprost API manufacturing?
A1: India, China, and Europe are the main regions, with India and China dominating volume and cost-efficiency.

Q2: How do I verify the quality of a bulk API supplier?
A2: Check for GMP and ISO certifications, review Certificates of Analysis, and conduct supplier audits if necessary.

Q3: Are there patent restrictions on sourcing Bimatoprost?
A3: Sourcing from licensed, authorized manufacturers ensures compliance with patent laws and regulatory clearance.

Q4: What factors influence API pricing?
A4: Production scale, synthesis complexity, regional manufacturing costs, and supplier certifications.

Q5: How can supply chain risks be minimized?
A5: Engage multiple approved suppliers, establish long-term contracts, and verify regulatory compliance.

---

References

1. Novartis. (2022). Sandoz API manufacturing capabilities. [Online]. Available at: www.sandoz.com [Accessed 2023].
2. Cipla. (2023). API sourcing and manufacturing standards. [Online]. Available at: www.cipla.com [Accessed 2023].
3. European Directorate for the Quality of Medicines & HealthCare. (2022). API Quality Standards. [Online]. Available at: www.edqm.eu [Accessed 2023].
4. Indian Pharmacopoeia Commission. (2021). Official API standards. [Online]. Available at: www.ipc.gov.in [Accessed 2023].